A review of pathology reporting for breast cancer

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 11, 1996, Pages 723-726

  Raj Wijetunga, L H ^a   Carmalt, Hugh L ^a   Gillett, David J ^a,b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b The Breast Centre Australia   (Australia)

Author keywords

Breast; Carcinoma; Pathology; Standards

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM INVASIVENESS; PATHOLOGY, CLINICAL;

EID: 10244247767     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kempson RL. The time is now. Checklists for surgical pathology reports. Arch. Pathol. Lab. Med. 1992; 116: 1107-8.
2. Cotran RS, Kumar V, Robbins SL. The breast. In: WB Saunders (ed.). Robbins Pathologic Basis of Disease. Philadelphia: Harcourt Brace Jovanovich Inc., 1989; Ch. 25.
3. Breast Cancer Consensus Conference, Royal Pines Resort Hotel, Queensland, 15-17 June, 1994.
4. Zarbo RJ. Interinstitutional assessment of colorectal carcinoma surgical pathology report adequacy. A College of American Pathologists Q-probes study of practice patterns from 532 laboratories and 15 940 reports. Arch. Pathol. Lab. Med. 1992; 116: 1113-19.
5. Azzopardi JG, Chepick OF, Hartmann WH et al. World Health Organization Histological Typing of Breast Tumors (2nd edn.). Am. J. Clin. Pathol. 1982; 78: 806-16.
6. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br. J. Cancer 1957; 11: 359-77.
7. Elston CW. Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ (eds). Diagnostic Histopathology of the Breast. New York: Churchill Livingstone Inc., 1987.
8. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
9. Castagnetta L, Traina A, Carruba G, Fecarotta E, Palazzotto G, Leake R. The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes. Br. J. Cancer 1992; 66: 167-70.
10. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up, Histopathology 1992; 20: 479-89.
11. Collett K, Maehle BO, Skjaerven R, Hartveit F. Lymph nodenegative breast cancer: The prognostic role and time dependency of age, tumor diameter and mean nuclear area. Oncology 1994; 51: 323-8.
12. Korzeniowski S, Dyba T, Skolyszewski J. Classical prognostic factors for survival and loco-regional control in breast cancer patients treated with radical mastectomy alone. Acta Oncol. 1994; 33: 759-65.
13. Nab HW, Kluck HM, Rutgers EJ, Coebergh JW, Hop WC. Long-term prognosis of breast cancer: An analysis of 462 patients in a general hospital in south-east Netherlands. Eur. J. Surg. Oncol. 1995; 21: 42-6.
14. Fisher ER, Redmond C, Fisher B. Prognostic factors in NSABBP studies of women with node-negative breast cancer. National Surgical Adjuvant Breast and Bowel Project. Monogr. Natl Cancer Inst. 1992; 11: 151-8.
15. Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22 616 cases of breast cancer. The basis for a prognostic index. Cancer 1991; 68: 2142-9.
16. Rakowsky E, Klein B, Kahan E, Derazne E, Lurie H. Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res. Treat. 1992; 21: 121-31.
17. Mink D, von Tongelen B, Villena-Heinsen C, Heiss C, Schmidt W. Breast cancer and prognostic factors. Tumour size, degree of differentiation, proliferation kinetics and expression of steroid hormone receptors. Eur. J. Gynaecol. Oncol. 1994; 15: 424-36.
18. Donegan WL. Prognostic factors. Stage and receptor status in breast cancer. Cancer 1992; 70: 1755-64.
19. Guinee VF, Olsson H, Moller T el al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 1993; 71: 154-61.
20. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551-7.
21. Advisory Group on Quality Assurance in Pathology in Breast Cancer Screening. Pathology Reporting in Breast Cancer Screening. Oxford: Screening Publications. 1990.
22. Neville AM, Bettelheim R, Gelber RD et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J. Clin. Oncol. 1992; 10: 696-705.
23. Barbareschi M, Dalla Palma P, Bevilacqua P et al. Invasive node-negative breast carcinoma: Multivariate analysis of the prognostic value of peritumoral vessel invasion compared with that of conventional clinico-pathologic features. Anticancer Res. 1994; 14: 2229-35.
24. Pinder SE. Ellis IO, Galea M. O'Rouke S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. III. Vascular invasion: Relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994; 24: 41-47.
25. Aaltomaa S, Lipponen P, Eskelinen M et al. Histological assessment of the prognostic factors in female breast cancer. Oncology 1992a; 49: 1-8.
26. Aaltomaa S, Lipponen P, Eskelinen M et al. Prognostic factors after 5 years follow-up in female breast cancer. Oncology 1992b; 49: 93-8.
27. Mireki DM, Jordan VC. Steroid hormone receptors and human breast cancer. Lab. Med. 1985; 16: 287.
28. Aaltomaa S, Lipponen P, Eskelinen M et al. Hormone receptors as prognostic factors in female breast cancer. Ann. Med. 1991; 23: 643-8.
29. Fisher B, Redmond C, Fisher ER. Relative worth of estrogen and progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J. Clin. Oncol. 1988; 6: 1076-87.
30. Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM. Estrogen and progesterone receptor mRNA levels in primary breast cancer: Association with patient survival and other clinical and tumor features. Int. J. Cancer 1994; 59: 351-6.